- Hologic (NASDAQ:HOLX) fiscal Q4 results ($M): Total Revenues: 702.8 (+6.4%); Diagnostics: 304.2 (-4.1%); Breast Health: 286.3 (+18.6%); GYN Surgical: 86.8 (+10.6%); Skeletal Health: 25.5 (+9.0%).
- Net Income: 25.2 (-10.6%); EPS: 0.09 (-10.0%); Non-GAAP EPS: 0.43 (unch); CF Ops (12 mo.): 786.1 (+54.6%).
-
Fiscal Q1 Guidance: Total Revenues: $680M - 690M; Non-GAAP EPS: $1.80 - 1.84.
-
Fiscal 2016 Guidance: Total Revenues: $2,810M - 2,840M; Non-GAAP EPS: $1.80 - 1.84.
- Shares are unchanged in after hours trading.